Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $29.0 million.

  • Mesa Laboratories' Cash & Equivalents rose 605.4% to $29.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $29.0 million, marking a year-over-year increase of 605.4%. This contributed to the annual value of $27.3 million for FY2025, which is 316.51% down from last year.
  • Latest data reveals that Mesa Laboratories reported Cash & Equivalents of $29.0 million as of Q4 2025, which was up 605.4% from $20.4 million recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' Cash & Equivalents ranged from a high of $278.3 million in Q3 2021 and a low of $20.4 million during Q3 2025
  • Over the past 5 years, Mesa Laboratories' median Cash & Equivalents value was $30.7 million (recorded in 2023), while the average stood at $67.8 million.
  • As far as peak fluctuations go, Mesa Laboratories' Cash & Equivalents surged by 22423.81% in 2021, and later crashed by 8836.59% in 2022.
  • Mesa Laboratories' Cash & Equivalents (Quarter) stood at $51.7 million in 2021, then plummeted by 49.52% to $26.1 million in 2022, then grew by 8.13% to $28.2 million in 2023, then dropped by 3.2% to $27.3 million in 2024, then grew by 6.05% to $29.0 million in 2025.
  • Its last three reported values are $29.0 million in Q4 2025, $20.4 million for Q3 2025, and $21.3 million during Q2 2025.